HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark P Boldin Selected Research
Mark P Boldin Research Topics
Disease
6
Inflammation (Inflammations)
01/2021 - 01/2002
4
Neoplasms (Cancer)
11/2017 - 01/2007
3
Infections
01/2021 - 02/2007
1
Neuroinflammatory Diseases
01/2022
1
Cytokine Release Syndrome
01/2020
1
Hypersensitivity (Allergy)
01/2020
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1
Splenomegaly
01/2017
1
Bone Marrow Failure Disorders
01/2017
1
Breast Neoplasms (Breast Cancer)
04/2014
Drug/Important Bio-Agent (IBA)
5
MicroRNAs (MicroRNA)
IBA
11/2017 - 01/2007
2
NF-kappa B (NF-kB)
IBA
10/2014 - 05/2011
1
Lipopolysaccharides
IBA
01/2022
1
Interleukin-8 (Interleukin 8)
IBA
01/2021
1
Chemokines
IBA
01/2021
1
Green Fluorescent Proteins
IBA
01/2021
1
Interferons
IBA
01/2021
1
Cell-Penetrating Peptides
IBA
01/2021
1
Chimeric Antigen Receptors
IBA
01/2020
1
Interleukin-1 (Interleukin 1)
IBA
01/2020
1
Oligonucleotides
IBA
01/2020
1
Interleukin-6 (Interleukin 6)
IBA
01/2020
1
TNF Receptor-Associated Factor 6 (TRAF6)
IBA
01/2017
1
Interleukin-1 Receptor-Associated Kinases
IBA
10/2014
1
Proteins (Proteins, Gene)
FDA Link
10/2014
1
Zonula Occludens-1 Protein
IBA
04/2014
1
Transcription Factors (Transcription Factor)
IBA
03/2012
1
Ligands
IBA
01/2002
Therapy/Procedure
1
Intranasal Administration
01/2021
1
Injections
01/2020